Baidu
map
CANCER GENE THER 润色咨询

CANCER GENE THERAPY

出版年份：1994 年文章数：762 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：3.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤基础研究<br>经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：刚刚在线发表了一篇，推荐给大家。 <br> 近几年IF年年涨，希望明年破5分。 <br> 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 <br> 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;生信<br>经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真 但是有一些专家可能处于起步阶段 提出的建议偶有奇葩 比如明显用语言语法编辑软件通看全文 什么意见都不提 专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]
    2023-11-15 摩西 来自河南省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：肿瘤
    经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form.

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤基础研究<br>经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：刚刚在线发表了一篇，推荐给大家。 <br> 近几年IF年年涨，希望明年破5分。 <br> 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 <br> 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;生信<br>经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真 但是有一些专家可能处于起步阶段 提出的建议偶有奇葩 比如明显用语言语法编辑软件通看全文 什么意见都不提 专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]
    2023-06-26 ms8000000927816250 来自上海

    2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤基础研究<br>经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：刚刚在线发表了一篇，推荐给大家。 <br> 近几年IF年年涨，希望明年破5分。 <br> 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 <br> 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;生信<br>经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真 但是有一些专家可能处于起步阶段 提出的建议偶有奇葩 比如明显用语言语法编辑软件通看全文 什么意见都不提 专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]
    2022-06-06 ms8000001211461628

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向：肿瘤基础研究
    经验分享：需提供WB原始条带，qPCR原始CT值

    8

    展开8条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤基础研究<br>经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：刚刚在线发表了一篇，推荐给大家。 <br> 近几年IF年年涨，希望明年破5分。 <br> 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 <br> 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;生信<br>经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真 但是有一些专家可能处于起步阶段 提出的建议偶有奇葩 比如明显用语言语法编辑软件通看全文 什么意见都不提 专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]
    2019-10-08 童话1024

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：刚刚在线发表了一篇，推荐给大家。
    近几年IF年年涨，希望明年破5分。
    小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。
    2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。

    6

    展开6条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤基础研究<br>经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：刚刚在线发表了一篇，推荐给大家。 <br> 近几年IF年年涨，希望明年破5分。 <br> 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 <br> 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;生信<br>经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真 但是有一些专家可能处于起步阶段 提出的建议偶有奇葩 比如明显用语言语法编辑软件通看全文 什么意见都不提 专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]
    2022-08-04 归浆

    请问生信友好吗

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤基础研究<br>经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：刚刚在线发表了一篇，推荐给大家。 <br> 近几年IF年年涨，希望明年破5分。 <br> 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 <br> 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;生信<br>经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真 但是有一些专家可能处于起步阶段 提出的建议偶有奇葩 比如明显用语言语法编辑软件通看全文 什么意见都不提 专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]
    2022-07-02 qiuqiu96

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：肿瘤;生信
    经验分享：纯生信，1周拒绝，建议转投scientific reports

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤基础研究<br>经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：刚刚在线发表了一篇，推荐给大家。 <br> 近几年IF年年涨，希望明年破5分。 <br> 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 <br> 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;生信<br>经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真 但是有一些专家可能处于起步阶段 提出的建议偶有奇葩 比如明显用语言语法编辑软件通看全文 什么意见都不提 专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]
    2022-05-29 Neville Wang

    评审专家很认真 但是有一些专家可能处于起步阶段 提出的建议偶有奇葩 比如明显用语言语法编辑软件通看全文 什么意见都不提 专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤基础研究<br>经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：刚刚在线发表了一篇，推荐给大家。 <br> 近几年IF年年涨，希望明年破5分。 <br> 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 <br> 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;生信<br>经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真 但是有一些专家可能处于起步阶段 提出的建议偶有奇葩 比如明显用语言语法编辑软件通看全文 什么意见都不提 专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]
    2021-12-28 乌云背后的幸福线

    如果文章发表了未提供ORCIDID如何添加？

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤基础研究<br>经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：刚刚在线发表了一篇，推荐给大家。 <br> 近几年IF年年涨，希望明年破5分。 <br> 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 <br> 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;生信<br>经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真 但是有一些专家可能处于起步阶段 提出的建议偶有奇葩 比如明显用语言语法编辑软件通看全文 什么意见都不提 专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]
    2021-12-27 衣谷

    什么是SCI？

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤基础研究<br>经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：刚刚在线发表了一篇，推荐给大家。 <br> 近几年IF年年涨，希望明年破5分。 <br> 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 <br> 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;生信<br>经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真 但是有一些专家可能处于起步阶段 提出的建议偶有奇葩 比如明显用语言语法编辑软件通看全文 什么意见都不提 专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]
    2021-12-09 ms8000001227904366

    无

    0

共71条页码: 1/8页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map